CHICAGO — A new diagnostic scale correlated with best corrected visual acuity and could serve as an alternative to evaluate disease activity in neovascular age-related macular degeneration, according to a study.
At Retina Subspecialty Day at the American Academy of Ophthalmology meeting, Usha Chakravarthy, MBBS, PhD, said there is a known negative correlation between commonly used markers, such as foveal retinal thickness and central subfield thickness (CST), and BCVA in patients with neovascular AMD, so new diagnostic tools are needed.
“There is a lot of variation and disconnect